Results: 104
TCERG1L allelic variation is associated with cisplatin-induced hearing loss in childhood cancer, a PanCareLIFE study.
- Published in:
- NPJ Precision Oncology, 2021, v. 5, n. 1, p. 1, doi. 10.1038/s41698-021-00178-z
- By:
- Publication type:
- Article
Validation of a liquid biopsy assay with molecular and clinical profiling of circulating tumor DNA.
- Published in:
- NPJ Precision Oncology, 2021, v. 5, n. 1, p. 1, doi. 10.1038/s41698-021-00202-2
- By:
- Publication type:
- Article
Bevacizumab improves tumor infiltration of mature dendritic cells and effector T-cells in triple-negative breast cancer patients.
- Published in:
- NPJ Precision Oncology, 2021, v. 5, n. 1, p. 1, doi. 10.1038/s41698-021-00197-w
- By:
- Publication type:
- Article
Pentraxin 3 is a stromally-derived biomarker for detection of pancreatic ductal adenocarcinoma.
- Published in:
- NPJ Precision Oncology, 2021, v. 5, n. 1, p. 1, doi. 10.1038/s41698-021-00192-1
- By:
- Publication type:
- Article
Genetic program activity delineates risk, relapse, and therapy responsiveness in multiple myeloma.
- Published in:
- NPJ Precision Oncology, 2021, v. 5, n. 1, p. 1, doi. 10.1038/s41698-021-00185-0
- By:
- Publication type:
- Article
Criteria-based curation of a therapy-focused compendium to support treatment recommendations in precision oncology.
- Published in:
- NPJ Precision Oncology, 2021, v. 5, n. 1, p. 1, doi. 10.1038/s41698-021-00194-z
- By:
- Publication type:
- Article
A computational method for prioritizing targeted therapies in precision oncology: performance analysis in the SHIVA01 trial.
- Published in:
- NPJ Precision Oncology, 2021, v. 5, n. 1, p. 1, doi. 10.1038/s41698-021-00191-2
- By:
- Publication type:
- Article
Comprehensive molecular profiling of pulmonary pleomorphic carcinoma.
- Published in:
- NPJ Precision Oncology, 2021, v. 5, n. 1, p. 1, doi. 10.1038/s41698-021-00201-3
- By:
- Publication type:
- Article
The pan-cancer landscape of crosstalk between epithelial-mesenchymal transition and immune evasion relevant to prognosis and immunotherapy response.
- Published in:
- NPJ Precision Oncology, 2021, v. 5, n. 1, p. 1, doi. 10.1038/s41698-021-00200-4
- By:
- Publication type:
- Article
A subset of lung cancer cases shows robust signs of homologous recombination deficiency associated genomic mutational signatures.
- Published in:
- NPJ Precision Oncology, 2021, v. 5, n. 1, p. 1, doi. 10.1038/s41698-021-00199-8
- By:
- Publication type:
- Article
Deep learning for end-to-end kidney cancer diagnosis on multi-phase abdominal computed tomography.
- Published in:
- NPJ Precision Oncology, 2021, v. 5, n. 1, p. 1, doi. 10.1038/s41698-021-00195-y
- By:
- Publication type:
- Article
A DNA methylation-based liquid biopsy for triple-negative breast cancer.
- Published in:
- NPJ Precision Oncology, 2021, v. 5, n. 1, p. 1, doi. 10.1038/s41698-021-00198-9
- By:
- Publication type:
- Article
Cancer-specific immune evasion and substantial heterogeneity within cancer types provide evidence for personalized immunotherapy.
- Published in:
- NPJ Precision Oncology, 2021, v. 5, n. 1, p. 1, doi. 10.1038/s41698-021-00196-x
- By:
- Publication type:
- Article
Pan-cancer analysis of SETD2 mutation and its association with the efficacy of immunotherapy.
- Published in:
- NPJ Precision Oncology, 2021, v. 5, n. 1, p. 1, doi. 10.1038/s41698-021-00193-0
- By:
- Publication type:
- Article
Overcoming resistance to BRAFV600E inhibition in melanoma by deciphering and targeting personalized protein network alterations.
- Published in:
- NPJ Precision Oncology, 2021, v. 5, n. 1, p. 1, doi. 10.1038/s41698-021-00190-3
- By:
- Publication type:
- Article
PARP inhibitors promote stromal fibroblast activation by enhancing CCL5 autocrine signaling in ovarian cancer.
- Published in:
- NPJ Precision Oncology, 2021, v. 5, n. 1, p. 1, doi. 10.1038/s41698-021-00189-w
- By:
- Publication type:
- Article
The L730V/I RET roof mutations display different activities toward pralsetinib and selpercatinib.
- Published in:
- NPJ Precision Oncology, 2021, v. 5, n. 1, p. 1, doi. 10.1038/s41698-021-00188-x
- By:
- Publication type:
- Article
Integrated molecular characterisation of endometrioid ovarian carcinoma identifies opportunities for stratification.
- Published in:
- NPJ Precision Oncology, 2021, v. 5, n. 1, p. 1, doi. 10.1038/s41698-021-00187-y
- By:
- Publication type:
- Article
Identification of gastric cancer subtypes based on pathway clustering.
- Published in:
- NPJ Precision Oncology, 2021, v. 5, n. 1, p. 1, doi. 10.1038/s41698-021-00186-z
- By:
- Publication type:
- Article
Models that combine transcriptomic with spatial protein information exceed the predictive value for either single modality.
- Published in:
- NPJ Precision Oncology, 2021, v. 5, n. 1, p. 1, doi. 10.1038/s41698-021-00184-1
- By:
- Publication type:
- Article
Targeting the epichaperome as an effective precision medicine approach in a novel PML-SYK fusion acute myeloid leukemia.
- Published in:
- NPJ Precision Oncology, 2021, v. 5, n. 1, p. 1, doi. 10.1038/s41698-021-00183-2
- By:
- Publication type:
- Article
Multiscale-omic assessment of EWSR1-NFATc2 fusion positive sarcomas identifies the mTOR pathway as a potential therapeutic target.
- Published in:
- NPJ Precision Oncology, 2021, v. 5, n. 1, p. 1, doi. 10.1038/s41698-021-00177-0
- By:
- Publication type:
- Article
Will polygenic risk scores for cancer ever be clinically useful?
- Published in:
- NPJ Precision Oncology, 2021, v. 5, n. 1, p. 1, doi. 10.1038/s41698-021-00176-1
- By:
- Publication type:
- Article
Next-generation sequencing revealed recurrent ZFPM1 mutations in encapsulated papillary carcinoma of the breast.
- Published in:
- NPJ Precision Oncology, 2021, v. 5, n. 1, p. 1, doi. 10.1038/s41698-021-00180-5
- By:
- Publication type:
- Article
A multi-omics study links TNS3 and SEPT7 to long-term former smoking NSCLC survival.
- Published in:
- NPJ Precision Oncology, 2021, v. 5, n. 1, p. 1, doi. 10.1038/s41698-021-00182-3
- By:
- Publication type:
- Article
A tyrosine kinase inhibitor-induced interferon response positively associates with clinical response in EGFR-mutant lung cancer.
- Published in:
- NPJ Precision Oncology, 2021, v. 5, n. 1, p. 1, doi. 10.1038/s41698-021-00181-4
- By:
- Publication type:
- Article
Deep learning for diagnosis of acute promyelocytic leukemia via recognition of genomically imprinted morphologic features.
- Published in:
- NPJ Precision Oncology, 2021, v. 5, n. 1, p. 1, doi. 10.1038/s41698-021-00179-y
- By:
- Publication type:
- Article
Knockout of immunotherapy prognostic marker genes eliminates the effect of the anti-PD-1 treatment.
- Published in:
- NPJ Precision Oncology, 2021, v. 5, n. 1, p. 1, doi. 10.1038/s41698-021-00175-2
- By:
- Publication type:
- Article
A genomic mutation signature predicts the clinical outcomes of immunotherapy and characterizes immunophenotypes in gastrointestinal cancer.
- Published in:
- NPJ Precision Oncology, 2021, v. 5, n. 1, p. 1, doi. 10.1038/s41698-021-00172-5
- By:
- Publication type:
- Article
Computer extracted gland features from H&E predicts prostate cancer recurrence comparably to a genomic companion diagnostic test: a large multi-site study.
- Published in:
- NPJ Precision Oncology, 2021, v. 5, n. 1, p. 1, doi. 10.1038/s41698-021-00174-3
- By:
- Publication type:
- Article
Epigenomics and immunotherapeutic advances in pediatric brain tumors.
- Published in:
- NPJ Precision Oncology, 2021, v. 5, n. 1, p. 1, doi. 10.1038/s41698-021-00173-4
- By:
- Publication type:
- Article
Digital Display Precision Predictor: the prototype of a global biomarker model to guide treatments with targeted therapy and predict progression-free survival.
- Published in:
- NPJ Precision Oncology, 2021, v. 5, n. 1, p. 1, doi. 10.1038/s41698-021-00171-6
- By:
- Publication type:
- Article
Microsecond-timescale MD simulation of EGFR minor mutation predicts the structural flexibility of EGFR kinase core that reflects EGFR inhibitor sensitivity.
- Published in:
- NPJ Precision Oncology, 2021, v. 5, n. 1, p. 1, doi. 10.1038/s41698-021-00170-7
- By:
- Publication type:
- Article
Panels and models for accurate prediction of tumor mutation burden in tumor samples.
- Published in:
- NPJ Precision Oncology, 2021, v. 5, n. 1, p. 1, doi. 10.1038/s41698-021-00169-0
- By:
- Publication type:
- Article
Patient-derived organoids as a predictive biomarker for treatment response in cancer patients.
- Published in:
- NPJ Precision Oncology, 2021, v. 5, n. 1, p. 1, doi. 10.1038/s41698-021-00168-1
- By:
- Publication type:
- Article
Clinical application of a lung cancer organoid (tumoroid) culture system.
- Published in:
- NPJ Precision Oncology, 2021, v. 5, n. 1, p. 1, doi. 10.1038/s41698-021-00166-3
- By:
- Publication type:
- Article
Preoperative immune landscape predisposes adverse outcomes in hepatocellular carcinoma patients with liver transplantation.
- Published in:
- NPJ Precision Oncology, 2021, v. 5, n. 1, p. 1, doi. 10.1038/s41698-021-00167-2
- By:
- Publication type:
- Article
Characterizing advanced breast cancer heterogeneity and treatment resistance through serial biopsies and comprehensive analytics.
- Published in:
- NPJ Precision Oncology, 2021, v. 5, n. 1, p. 1, doi. 10.1038/s41698-021-00165-4
- By:
- Publication type:
- Article
Progression of prostate carcinoma is promoted by adipose stromal cell-secreted CXCL12 signaling in prostate epithelium.
- Published in:
- NPJ Precision Oncology, 2021, v. 5, n. 1, p. 1, doi. 10.1038/s41698-021-00160-9
- By:
- Publication type:
- Article
Inflation of tumor mutation burden by tumor-only sequencing in under-represented groups.
- Published in:
- NPJ Precision Oncology, 2021, v. 5, n. 1, p. 1, doi. 10.1038/s41698-021-00164-5
- By:
- Publication type:
- Article
Immune microenvironment characterisation and dynamics during anti-HER2-based neoadjuvant treatment in HER2-positive breast cancer.
- Published in:
- NPJ Precision Oncology, 2021, v. 5, n. 1, p. 1, doi. 10.1038/s41698-021-00163-6
- By:
- Publication type:
- Article
Complete response to PD-1 blockade following EBV-specific T-cell therapy in metastatic nasopharyngeal carcinoma.
- Published in:
- NPJ Precision Oncology, 2021, v. 5, n. 1, p. 1, doi. 10.1038/s41698-021-00162-7
- By:
- Publication type:
- Article
Circulating stromal cells in resectable pancreatic cancer correlates to pathological stage and predicts for poor clinical outcomes.
- Published in:
- NPJ Precision Oncology, 2021, v. 5, n. 1, p. 1, doi. 10.1038/s41698-021-00161-8
- By:
- Publication type:
- Article
Precision medicine: preliminary results from the Initiative for Molecular Profiling and Advanced Cancer Therapy 2 (IMPACT2) study.
- Published in:
- NPJ Precision Oncology, 2021, v. 5, n. 1, p. 1, doi. 10.1038/s41698-021-00159-2
- By:
- Publication type:
- Article
Acetylation of ELF5 suppresses breast cancer progression by promoting its degradation and targeting CCND1.
- Published in:
- NPJ Precision Oncology, 2021, v. 5, n. 1, p. 1, doi. 10.1038/s41698-021-00158-3
- By:
- Publication type:
- Article
Swiss-PO: a new tool to analyze the impact of mutations on protein three-dimensional structures for precision oncology.
- Published in:
- NPJ Precision Oncology, 2021, v. 5, n. 1, p. 1, doi. 10.1038/s41698-021-00156-5
- By:
- Publication type:
- Article
Dynamic roles of inflammasomes in inflammatory tumor microenvironment.
- Published in:
- NPJ Precision Oncology, 2021, v. 5, n. 1, p. 1, doi. 10.1038/s41698-021-00154-7
- By:
- Publication type:
- Article
Predictive and prognostic transcriptomic biomarkers in soft tissue sarcomas.
- Published in:
- NPJ Precision Oncology, 2021, v. 5, n. 1, p. 1, doi. 10.1038/s41698-021-00157-4
- By:
- Publication type:
- Article
Structural variant detection in cancer genomes: computational challenges and perspectives for precision oncology.
- Published in:
- NPJ Precision Oncology, 2021, v. 5, n. 1, p. 1, doi. 10.1038/s41698-021-00155-6
- By:
- Publication type:
- Article
Stabilization of p18 by deubiquitylase CYLD is pivotal for cell cycle progression and viral replication.
- Published in:
- NPJ Precision Oncology, 2021, v. 5, n. 1, p. 1, doi. 10.1038/s41698-021-00153-8
- By:
- Publication type:
- Article